Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer

Annals of Thoracic Surgery

Volumn 80, Issue 2, 2005, Pages 409-417

  Adusumilli, Prasad S ^a   Stiles, Brendon M ^a   Chan, Mei Ki ^a   Chou, Ting Chao ^a   Wong, Richard J ^a   Rusch, Valerie W ^a   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; PROTEIN; PROTEIN GADD34; RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER RADIOTHERAPY; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LUNG CARCINOMA; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, DIFFERENTIATION; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DNA DAMAGE; HERPESVIRUS 1, HUMAN; HUMANS; LUNG NEOPLASMS; MICE; ONCOLYTIC VIROTHERAPY; RADIOTHERAPY; UP-REGULATION; VERO CELLS; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 22544467233     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.01.048     Document Type: Article

References (30)

1. Cancer Facts & Figures 2004 Available at: http://www.cancer.org/ downloads/STT?CAFF_finalPWSecured.pdf. Accessed October 30, 2004
2. F. Sirzen, E. Kjellen, S. Sorenson, E. Cavallin-Stahl A systematic overview of radiation therapy effects in non-small cell lung cancer Acta Oncol 42 2003 493 515
3. J.D. Cox, W.T. Sause, R.W. Byhardt, R. Komaki, C.A. Perez, T.F. Pajak Dose intensity of radiation therapy in non-small cell carcinoma of the lung a review of RTOG data and strategies Lung Cancer 10 Suppl 1 1994 S161 S166
4. C.A. Perez, T.F. Pajak, P. Rubin Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group Cancer 59 1987 1874 1881
5. K.E. Rosenzweig, E. Yorke, A. Jackson Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer Int J Radiat Oncol Biol Phys 57 2 Suppl 2003 S417 S418
6. T. Mineta, S.D. Rabkin, T. Yazaki, W.D. Hunter, R.L. Martuza Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas Nat Med 1 1995 938 943
7. Y. Fong, N. Kemeny, S. Jarnagin Phase 1 study of a replication-competent herpes simplex oncolytic virus for treatment of hepatic colorectal metastases Vol. 2 2002 Proceedings of the American Society of Clinical Oncology, 38th Annual Meeting, Part 1, 8a, abstract 27
8. B.M. Stiles, A. Bhargava, P.S. Adusumilli The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer Surgery 134 2003 357 364
9. S.F. Stanziale, B.M. Stiles, A. Bhargava, S.A. Kerns, N. Kalakonda, Y. Fong Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer Hum Gene Ther 15 2004 609 618
10. S.F. Stanziale, Y. Fong Novel approaches to cancer therapy using oncolytic viruses Curr Mol Med 3 2003 61 71
11. D.A. Kooby, J.F. Carew, M.W. Halterman Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207) FASEB J 13 1999 1325 1334
12. M.I. Ebright, J.S. Zager, S. Malhotra Replication-competent herpes virus NV1020 as direct treatment of pleural cancer in a rat model J Thorac Cardiovasc Surg 124 2002 123 129
13. B.M. Stiles, P.S. Adusumilli, A. Bhargava Minimally-invasive in vivo imaging of an oncolytic herpes simplex mutant expressing green fluorescent protein Mol Ther 7 2003 S453 abstract 1172
14. S.F. Stanziale, H. Petrowsky, P.S. Adusumilli Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells a potential target to increase anticancer activity Clin Cancer Res 10 2004 3225 3232
15. R.J. Wong, J.K. Joe, S.H. Kim, J.P. Shah, B. Horsburgh, Y. Fong Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases Hum Gene Ther 13 2002 1213 1223
16. M.C. Hollander, Q. Zhan, I. Bae, A.J. Fornace Jr Mammalian GADD34, an apoptosis- and DNA damage-inducible gene J Biol Chem 272 1997 13731-7
17. M.C. Hollander, S. Poola-Kella, A.J. Fornace Jr GADD34 functional domains involved in growth suppression and apoptosis Oncogene 22 2003 3827 3832
18. M.C. Hollander, M.S. Sheikh, K. Yu Activation of GADD34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors Int J Cancer 96 2001 22 31
19. S.F. Stanziale, H. Petrowsky, J.K. Joe Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase Surgery 132 2002 353 359
20. J.J. Bennett, K.A. Delman, B.M. Burt Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer Cancer Gene Ther 9 2002 935 945
21. S.J. Advani, S.M. Chung, S.Y. Yan Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors Cancer Res 59 1999 2055 2058
22. T.C. Chou, P. Talalay Quantitative analysis of dose-effect relationships the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
23. J.J. Bennett, P. Adusumilli, H. Petrowsky Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207) FASEB J 18 2004 1001 1003
24. The siRNA user guide 2004 Available at: http://www.rockefeller.edu/ labheads/tuschl/sirna.html. Accessed October 30, 2004
25. C.M. Kramm, M. Chase, U. Herrlinger Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy Hum Gene Ther 8 1997 2057 2068
26. R.Y. Chung, Y. Saeki, E.A. Chiocca B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells J Virol 73 1999 7556 7564
27. T.C. Chou Assessment of synergistic and antagonistic effects of chemotherapeutic agents in vitro Contrib Gynecol Obstet 19 1994 91 107
28. T.C. Chou Quantitation of synergism and antagonism of two or more drugs by computerized analysis 2004 Academic Press New York 223 244
29. S.A. Amundson, T.G. Myers, D. Scudiero, S. Kitada, J.C. Reed, A.J. Fornace Jr An informatics approach identifying markers of chemosensitivity in human cancer cell lines Cancer Res 60 2000 6101 6110
30. A.J. Fornace Jr, S.A. Amundson, M. Bittner The complexity of radiation stress responses analysis by informatics and functional genomics approaches Gene Expr 7 1999 387 400